N. Schleucher

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Dirk Strumberg, Heike Richly, Ralf A. Hilger et al. · Journal of Clinical Oncology · 2004 · 871 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo et al. · Journal of Clinical Oncology · 2003 · 259 citations

Medicine, Oncology, Pharmacology +15

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Hans‐Joachim Schmoll, Christian Kollmannsberger, Bernd Metzner et al. · Journal of Clinical Oncology · 2003 · 160 citations

Medicine, Oncology, Chemotherapy +15

Activity of Oxaliplatin in Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group

Christian Kollmannsberger, Oliver Rick, H. G. Derigs et al. · Journal of Clinical Oncology · 2002 · 108 citations

Medicine, Oncology, Pharmacology +17

First-line high-dose chemotherapy ± radiation therapy in patients with metastatic germ-cell cancer and brain metastases

Christian Kollmannsberger, Craig R. Nichols, M. Bamberg et al. · Annals of Oncology · 2000 · 67 citations · Full text

Medicine, Oncology, Radiation Oncology +16